Filana Therapeutics Stock (NASDAQ:FLNA)
Previous Close
$2.00
52W Range
$1.15 - $4.98
50D Avg
$2.11
200D Avg
$2.51
Market Cap
$92.27M
Avg Vol (3M)
$775.15K
Beta
-0.84
Div Yield
-
FLNA Company Profile
Filana Therapeutics, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.